Skip to content

Closed-Loop Fluid Administration System Using Hemodynamic Monitors

Closed-Loop Fluid Administration System Using Hemodynamic Monitors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02020863
Enrollment
40
Registered
2013-12-25
Start date
2012-11-30
Completion date
2014-05-31
Last updated
2016-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraoperative Volume Status, Postoperative Complications

Brief summary

The purpose of this study is to evaluate the feasibility of a closed-loop (automated) fluid administration system to deliver fluids using feedback from standard operating room hemodynamic monitors. In standard anesthesia care the rate of IV fluid administration to the patient is determined by the anesthesiologist caring for the patient. In this study protocol, the rate of fluid administration will be determined instead by the closed-loop (automated) control system under the supervision of the anesthesiologist. The system will independently decide when to give fluid and at what rate; the supervising anesthesiologist will monitor the system to ensure appropriate volumes are being delivered and to intervene if necessary.

Detailed description

In our protocol we will test the hypothesis that closed-loop fluid administration can maintain higher cardiac stroke volume (shown to improve patient outcomes after surgery) than anesthesiologist management. We have shown this to be the case in multiple simulation studies and in-vivo animal studies, but not yet experimentally in a clinical setting. Investigators will recruit their patients from the surgical record that that require cardiac output monitoring undergoing surgery and require mechanical ventilation and consent to participate in the study will be included in the study. They will receive standard patient care in that in no way will their anesthetic or surgical procedure will be altered as part of the study, with the exception of fluid administration. Fluids are usually given to a patient based on the physician's discretion. As part of the study patients will receive fluid management via a closed loop (automated) system that will use an infusion pump (Q-Core) and a controller (a computer run index and algorithm developed by Sironis) to make frequent, regular and accurate adjustments to the amount of fluid the patient receives using feedback from standard operating room monitors at UCI). Data from this study will be retrospectively compared to subjects case matched to evaluate differences in cardiac output, total fluid given, and patient outcomes.

Interventions

Fluid management in the closed loop group will be performed via a closed loop (automated) system that will use an infusion pump (Q-Core) and a controller (a computer run index and algorithm developed by Sironis) to make frequent, regular and accurate adjustments to the amount of fluid the patient receives using feedback from standard operating room monitors.

Sponsors

University of California, Irvine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult subjects (over the age of 18) * Subjects undergoing elective major, abdominal surgery * Subjects requiring general anesthesia and mechanical ventilation * Subjects requiring cardiac output monitoring and an arterial line

Exclusion criteria

* Subjects under 18 years of age * Subjects not undergoing surgery * Subjects not requiring general anesthesia or mechanical ventilation * Subjects not requiring cardiac output monitoring or an arterial line * Subjects who are pregnant * Subjects without the capacity to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Fluid Status During SurgeryDuration of Surgery, up to 8 hoursThe primary outcome between groups is preload independence, defined as % case time where Stroke Volume Variation (SVV) is ≤12%.

Countries

United States

Participant flow

Participants by arm

ArmCount
Closed Loop
Study patients will receive a baseline crystalloid infusion of 3 cc/kg/hr and all additional fluid management will be performed via a closed loop (automated) system that will determine rate, amount, and timing of fluid administration. Closed Loop: Fluid management in the closed loop group will be performed via a closed loop (automated) system that will use an infusion pump (Q-Core) and a controller (a computer run index and algorithm developed by Sironis) to make frequent, regular and accurate adjustments to the amount of fluid the patient receives using feedback from standard operating room monitors.
35
Total35

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyDiscovery of Metastatic disease4
Overall StudyTeam chose not to place an a line1

Baseline characteristics

CharacteristicClosed Loop
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
12 Participants
Age, Categorical
Between 18 and 65 years
23 Participants
Age, Continuous61.6 years
STANDARD_DEVIATION 12.8
ASA Physical Status patient classification
2
1 participants
ASA Physical Status patient classification
3
28 participants
ASA Physical Status patient classification
4
6 participants
Region of Enrollment
United States
35 participants
Sex: Female, Male
Female
16 Participants
Sex: Female, Male
Male
19 Participants
Specific Surgical procedure
Complex cholecystectomy
3 participants
Specific Surgical procedure
Distal pancreatectomy
5 participants
Specific Surgical procedure
Liver resection
10 participants
Specific Surgical procedure
Whipple
9 participants
Specific Surgical procedure
Whipple + additional
8 participants
Stroke Volume Index44 ml per meter-squared
STANDARD_DEVIATION 10

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 35
serious
Total, serious adverse events
0 / 35

Outcome results

Primary

Fluid Status During Surgery

The primary outcome between groups is preload independence, defined as % case time where Stroke Volume Variation (SVV) is ≤12%.

Time frame: Duration of Surgery, up to 8 hours

Population: Closed Loop Study population at Stroke Volume Variation (SVV) ≤12%

ArmMeasureValue (MEAN)Dispersion
Closed LoopFluid Status During Surgery95 percentage of case timeStandard Deviation 6

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026